Date of Report (Date of earliest event reported): May 26, 2016 |
GENMARK DIAGNOSTICS, INC. |
(Exact name of registrant as specified in its charter) Commission File Number: 001-34753 |
Delaware | 27-2053069 | |
(State or other jurisdiction of incorporation) | (I.R.S. Employer Identification No.) |
5964 La Place Court Carlsbad, California |
(Address of principal executive offices, including zip code) |
760-448-4300 |
(Registrant’s telephone number, including area code) |
(Former Name or Former Address, if Changed Since Last Report) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): |
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
1. | For the proposal to elect two nominees for director to serve a three-year term expiring at GenMark’s 2019 Annual Meeting of Stockholders, the voting results were as follows: |
Name of Directors Elected | For | Withhold | Broker Non-Votes | |||
Lisa M. Giles | 35,390,074 | 265,635 | 4,545,959 | |||
Michael S. Kagnoff | 27,747,173 | 7,908,536 | 4,545,959 |
2. | For the proposal to ratify Ernst & Young LLP as GenMark’s independent registered public accounting firm for the fiscal year ending December 31, 2016, the voting results were as follows: |
For | Against | Abstain | ||
40,179,188 | 9,979 | 12,501 |
3. | For the proposal to approve, on an advisory basis, the compensation of GenMark’s named executive officers, the voting results were as follows: |
For | Against | Abstain | Broker Non-Votes | |||
28,474,453 | 7,013,170 | 168,086 | 4,545,959 |